A - Agilent Technologies, Inc.

NYSE - NYSE Delayed Price. Currency in USD
64.47
-1.28 (-1.95%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close65.75
Open65.81
Bid59.70 x 1000
Ask75.00 x 1000
Day's Range64.24 - 66.24
52 Week Range60.42 - 75.00
Volume2,418,302
Avg. Volume2,290,707
Market Cap20.551B
Beta (3Y Monthly)1.32
PE Ratio (TTM)70.61
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.60 (0.91%)
Ex-Dividend Date2018-10-01
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire12 days ago

    Report: Exploring Fundamental Drivers Behind Ebix, Southwest Gas, Campbell Soup, La-Z-Boy, At Home Group, and Agilent Technologies — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, Oct. 08, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Business Wire19 days ago

    Agilent Brings Greater Clarity and Speed to Chemical Imaging

    Breakthrough System Takes Brand New Approach

  • Business Wire24 days ago

    ACEA Biosciences to be Acquired by Agilent Technologies

    Cell Analysis Just Got Better! ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE:A). ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries.

  • Business Wire24 days ago

    Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences

    Combined clinical reagent and instrument portfolio allows for optimized complete solutions. Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire privately-owned ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis instruments for life science research and clinical diagnostics, for $250 million in cash. “Expanding our cell analysis footprint is a key strategic growth initiative,” said Jacob Thaysen, president of Agilent’s Life Sciences and Applied Markets Group.

  • Business Wirelast month

    Agilent Technologies Announces Cash Dividend of 14.9 Cents per Share

    Agilent Technologies Inc. (NYSE:A) today announced that a quarterly dividend of 14.9 cents per share of common stock will be paid on October 24, 2018, to all shareholders of record as of the close of business on October 2, 2018. Agilent Technologies Inc. (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.

  • Business Wirelast month

    Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents

    Agilent Technologies Inc. filed a new complaint against Twist Bioscience Corp. and Emily Leproust. The proposed Second Amended Complaint adds two additional defendants and adds new facts that were recently discovered regarding the defendants’ wide-ranging theft of Agilent’s proprietary oligonucleotide synthesis technology.

  • Business Wirelast month

    Agilent Early Career Professor Award Presented to Christoph Thaiss at University of Pennsylvania

    Agilent Technologies Inc. (NYSE:A) today announced that the winner of the 2018 Agilent Early Career Professor Award is Christoph Thaiss, Ph.D., assistant professor of microbiology in the Perelman School of Medicine at the University of Pennsylvania. Dr. Thaiss’s research focuses on the microbiome and how it mediates the response of its host to environmental cues, which strongly influences the organism’s health and disease states. “We are very happy to support Dr. Thaiss and his transformative microbiome research," said Jack Wenstrand, director of University Relations and External Research at Agilent.

  • Business Wirelast month

    Agilent Recognized as Aon Best Employer in Malaysia for 2018

    Agilent Technologies Inc. (NYSE:A) today announced that it has been recognized as one of Aon’s Best Employers in Malaysia for 2018. Agilent received the honor from Aon at an award ceremony this week in Kuala Lumpur, Malaysia. Aon is a leading global professional services firm that provides a broad range of risk, retirement, and health solutions through its flagship program Aon Best Employers.

  • Business Wire2 months ago

    Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma

    PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA®

  • Business Wire2 months ago

    Agilent Receives 2018 IBO Industrial Design Gold Award for the Ultivo Triple Quadrupole LC/MS System

    Award Received for Excellence in Industrial Design

  • Business Wire2 months ago

    Agilent Completes Acquisition of Young In Scientific Co. Ltd. Assets

    Agilent Technologies Inc. (NYSE: A) today announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a leading distributor of analytical and scientific instruments in South Korea and a long-time distributor of Agilent instruments and services. Agilent and YI Scientific have enjoyed a strong partnership over many years.

  • Business Wire2 months ago

    Agilent Technologies Reports Third-Quarter Fiscal Year 2018 Financial Results

    Company Tops Third Quarter Revenue and EPS Guidance; Raising Full-Year Guidance

  • Business Wire2 months ago

    Agilent First to Release Software Supporting Standardized Data Format for Pharmaceutical Industry

    The ADF was designed to standardize the collection, exchange, and storage of analytical data captured in laboratory workflows. ADF enables labs to transfer and share data across platforms. “The development of ADF is an important step toward obtaining faster results and more insight from the data collected and produced within pharmaceutical organizations involved in research, development, and production of chemicals and biomolecules,” said John Sadler, vice president and general manager of Agilent’s Software and Informatics Division.

  • Business Wire2 months ago

    Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma

    PD-L1 IHC 22C3 pharmDx Can Now Be Used as an Aid to Identify Urothelial Carcinoma Patients for Treatment With KEYTRUDA®

  • Business Wire3 months ago

    Agilent Technologies Completes Acquisition of ProZyme

    Agilent Technologies, Inc. (NYSE:A) today announced that it has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. Founded in 1990, Hayward-Calif. based ProZyme is an industry leading developer and manufacturer of glycan reagents, kits and standards, which are required for efficient sample prep in the analysis of free glycans.

  • PR Newswire3 months ago

    Hologic Announces Chief Financial Officer Change

    -- Bob McMahon to Depart; Karleen Oberton, Chief Accounting Officer, Promoted to CFO -- MARLBOROUGH, Mass. , July 31, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that Chief Financial ...

  • Business Wire3 months ago

    Agilent Announces CFO Transition

    Agilent Technologies Inc. (NYSE:A) today announced that Didier Hirsch, senior vice president and chief financial officer, has decided to retire on Oct 31, 2018. The company has appointed Robert W. McMahon, currently chief financial officer, Hologic, Inc., as his successor. McMahon will join Agilent on August 3, as senior vice president, and will become CFO on Sept. 1, 2018, when Hirsch will step down as CFO.

  • ACCESSWIRE3 months ago

    Free Technical Research on Agilent Technologies and Three More Medical Research Equities

    On Monday, July 30, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Seven out of nine sectors ended Monday's trading session in bearish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Medical Laboratories & Research equities this morning: Agilent Technologies Inc. (NYSE: A), Co-Diagnostics Inc. (NASDAQ: CODX), Quest Diagnostics Inc. (NYSE: DGX), and Bruker Corp. (NASDAQ: BRKR).

  • GlobeNewswire3 months ago

    Recent Analysis Shows Kala Pharmaceuticals, Integer, Carnival, Coty, Sykes Enterprises, and Agilent Technologies Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, July 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Kala ...

  • Business Wire3 months ago

    Agilent Technologies to Host Webcast of Third-Quarter Fiscal Year 2018 Financial Results Conference Call

    Agilent Technologies Inc. will release third-quarter fiscal 2018 financial results after the stock market closes on August 14. The company will host a live webcast of its investor conference call in listen-only mode.

  • Business Wire3 months ago

    Agilent Receives Sustainability Leadership Award

    Agilent Technologies Inc. (NYSE:A) today announced that it has earned the 2018 Sustainability Leadership Award from the Business Intelligence Group for its commitment to sustainability through innovative product design. The Leadership Award, judged by a volunteer panel of leaders and experts in business, recognizes an organization whose actions over the last 12 months prove sustainability is a core business objective. According to the Business Intelligence Group, the Sustainability Awards program was founded with the mission of recognizing true talent and superior performance in the business world, honoring those who have made sustainability an integral part of their business practice.

  • Business Wire3 months ago

    UK Border Force Deploys Agilent Resolve Handheld Raman Systems for Hazardous Material Detection

    Agilent Technologies Inc. today announced that UK Border Force is now using Resolve, the company’s handheld Raman system, to detect bulk chemicals—whether benign, hazardous, or illegal—through opaque packages and containers.

  • Business Wire3 months ago

    Agilent and Grabner Instruments Provide Innovative Mobile Testing Solution for the Petroleum Industry

    Agilent Technologies Inc. (NYSE:A) announces an equipment manufacturing agreement with Grabner Instruments, a subsidiary of AMETEK, Inc. The agreement is focused on an innovative mobile testing solution for in-field analysis of lubricating oils and greases. Grabner Instruments, based in Austria, is well known for developing and manufacturing automatic petroleum testing equipment. In this partnership, Grabner will focus on lube and grease analysis, an area that requires specific and specialized expertise in method development.

  • Business Wire3 months ago

    Agilent Technologies Completes Acquisition of ULTRA Scientific Assets

    Agilent Technologies Inc. (NYSE: A) today announced that it has completed the acquisition of the business assets of ULTRA Scientific, Inc., a leading provider of chemical standards and certified reference materials. Agilent identified chemical standards as a key expansion area that will enable Agilent to enhance the customer experience by providing complete workflow solutions. ULTRA Scientific’s extensive catalog of chemical standards are critical to analytical laboratory workflows and help customers qualify the performance of their methods to validate and quantitate results.

  • Business Wire3 months ago

    Agilent and Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis

    Agilent Technologies Inc. (NYSE:A) today announced that it will collaborate with the Nanyang Technological University Singapore’s (NTU Singapore’s) Nanyang Environment Water Research Institute (NEWRI) to develop novel approaches to testing and monitoring the region’s water supply. Under a memorandum of understanding, the two organizations have agreed to address persistent and emerging contaminants in water. “We are pleased that, with this agreement, our shared vision and combined resources will be brought to bear on such a critical challenge,” said Nino Totino, Agilent vice president and general manager of Laboratory Solution Sales in the region.